Cosette Pharmaceuticals, Inc.

Cosette Pharma is thrilled to announce our presence at?CPHI?Worldwide 2024 in Milan!?From?October 8th-10th, we'll be at Fiera Milano, ready to connect, collaborate, and showcase our latest innovations. This is an exciting opportunity to meet with valued customers, partners, and industry leaders, as we explore new ways to grow and innovate together. Whether you're interested in our latest product offerings or looking to spark new business opportunities, we can't wait to see you there! Apurva Saraf, President and CEO Serge Ilin-Schneider, SVP - Corporate Development & General Counsel Ted Smolenski, VP - Portfolio and Business Development Ravi Patel, AVP - Head of R&D Geoffrey Brobst, Director - Strategic Sourcing - Corporate Supply Chain Jessica Puia, CSCP, Director - Supply Chain #CPHI2024 #CosettePharma #Innovation #BusinessOpportunities #PharmaIndustry

Cosette Pharmaceuticals is excited to announce our participation in the 27th?Annual National Association of Nurse Practitioners in Women's Health (NPWH) in Chicago during September 25-28, 2024.?Amy Thompson, Kerri McClain and Catherine Holtz are looking forward to engaging in insightful discussions and sharing our commitment to improving women’s health and wellness through innovative solutions. Come visit Amy, Kerri, and Catherine at booth 516. #CosettePharma; #womenshealthcare, #HSSD, #fertility, #NPWHConference

Avista Capital Partners, a leading healthcare-focused private equity firm, and Hamilton Lane (Nasdaq: HLNE), a global private markets investment management firm, announced today that funds managed by Hamilton Lane have acquired a significant equity interest in Cosette Pharmaceuticals from Avista and its co-investors. Going forward, Avista and Hamilton Lane will jointly control Cosette, focusing on accelerating innovation and growth. Apurva Saraf, President and CEO of Cosette, said, “This partnership highlights our remarkable transformation over the past four years. We are proud of our diversified portfolio, including branded products like Clomid?, Ambien?, and Benicar?, and innovative drugs like Vyleesi? and Intrarosa?. With strong R&D and business development, we are poised for substantial growth with Avista and Hamilton Lane." Full press release is here https://prn.to/4bRqQlM Avista Capital Partners Hamilton Lane UBS Santander Capital One Ropes & Gray LLP Hayfin Capital Management LLP #cosettepharma #mergers #healthcare #pharma

Cosette Pharma is very proud to announce the acquisition of Ambien??and Ambien CR??in the United States from Sanofi US! “We are excited at the addition of Ambien to our portfolio,” stated?Apurva Saraf?Saraf, President and CEO of Cosette. “We continue to leverage our demonstrated, best-in-class capabilities in executing complex carve-outs and integrating diverse products. This acquisition not only strengthens our product portfolio but also reaffirms our commitment to ensuring high-quality products continue to remain available to patients worldwide." For the complete press release, please?click here https://bwnews.pr/460JyWW Avista Capital Partners Sanofi #cosettepharma #healthcare #pharma #ambien #acquisition

? During World National Infertility Awareness month, we honor the courage of those facing infertility. At Cosette Pharma, we're proud to offer?Clomid? (clomiPHENE citrate), an affordable and effective prescription fertility treatment that has helped countless families realize their dreams. By making?Clomid? (clomiPHENE citrate), accessible, we're committed to supporting every hopeful parent on their journey to conception. Together, let's bring hope to those who need it the most. ?Please find Clomid package insert information at www.clomid.com?? #InfertilityAwareness #Clomid #Hope #Support #cosettepharma #infertility #fertilityjourney

We had an incredible time at the ACOG conference last week in San Fransisco, connecting with healthcare professionals and business partners. It was a fantastic opportunity to discuss our innovative products, Vyleesi and Clomid, with the experts in the field. Thank you to everyone who visited our booth and engaged in meaningful conversations. Your insights and enthusiasm drive us to continue our mission of advancing women's health, and innovating every day! #ACOG2024 #WomensHealth #PharmaInnovation #Healthcare #Vyleesi #Clomid

Cosette is excited to be?attending?the?ACOG?Annual meeting. Please be sure to connect with our team?Serge Ilin-Schneider,?Kevin Hickey,?Jackie Beltrani, Alain Y. Dury, PhD, and Sonali Batish?at booth 1317! #ACOG2024 #womenshealth #cosettepharma #pharmaconference

Cosette is proud to stand with?RESOLVE: The National Infertility Association, to raise awareness about infertility and the barriers that millions face in building their families. National Infertility Awareness Week is a great opportunity for us to support people who are looking to build families. #niaw2024?#niaw?#infertilityawareness?#infertilitysupport #infertilityjourney?#cosettepharma

At Cosette Pharma, we're pushing the boundaries of pharmaceutical development. A recent feature in a leading pharma journal spotlights our own Ravi Patel and Harshil Shah’s groundbreaking approach to complex generic dosage forms. Our novel methods not only ensure regulatory compliance but also enhance therapeutic outcomes, offering our CDMO clients cutting-edge solutions that are tailored for today's complex pharmaceutical landscape. Connect with us at?[email protected]?to dive deeper into our innovative techniques, including In Vitro–In Vivo Correlation (IVIVC) and Physiologically Based Pharmacokinetic (PBPK) Modeling, and discover how these advancements are setting new standards in drug development. We're excited to bring these capabilities to your next project. Let’s connect to explore how our innovative approaches can elevate your products. https://lnkd.in/e5Thz-ye #PharmaInnovation #CDMO #ComplexGenerics #Pharmaceuticals #DrugDevelopment #InnovationInPharma

We are excited to unveil Cosette Empowers, our Scholarship Program, in celebration of Employee Appreciation Month. This initiative lightens the load of higher education costs for our team members' children, embodying our "Innovating Every Day" ethos. It underscores our dedication to our employees and our patients, prescribers, and community, reinforcing our belief in education's power to transform. Here's to empowering the next generation and contributing to their future successes! #employeeappreciationmonth #empowering #education #pharma #healthcare #scholarship